At CPHI Worldwide 2015, Richmol showcased its capabilities in pharmaceutical intermediate R&D and process scale-up, exploring collaboration opportunities with global customers.
The team highlighted its supply capabilities for pyridine, pyrimidine and quinoline products, together with a service model covering route design, process optimization and scale-up validation around target structures. For customers in different markets, Richmol emphasized a stable quality system and clear communication milestones.
CPHI Worldwide provided a window to the global pharmaceutical supply chain and helped the team further define its direction in high-value intermediates and custom synthesis.